SI-BONE, Inc. (SIBN)
18.08
-0.33
(-1.79%)
USD |
NASDAQ |
Oct 02, 16:00
18.08
0.00 (0.00%)
After-Hours: 20:00
SI-BONE Enterprise Value : 704.98M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 704.98M |
| October 01, 2026 | 719.73M |
| September 30, 2026 | 737.16M |
| September 29, 2026 | 752.81M |
| September 28, 2026 | 735.37M |
| September 25, 2026 | 727.77M |
| September 24, 2026 | 724.65M |
| September 23, 2026 | 728.22M |
| September 22, 2026 | 737.61M |
| September 21, 2026 | 721.52M |
| September 18, 2026 | 705.43M |
| September 17, 2026 | 703.19M |
| September 16, 2026 | 725.54M |
| September 15, 2026 | 725.99M |
| September 14, 2026 | 732.69M |
| September 11, 2026 | 718.39M |
| September 10, 2026 | 714.81M |
| September 09, 2026 | 719.73M |
| September 08, 2026 | 729.12M |
| September 04, 2026 | 723.75M |
| September 03, 2026 | 730.01M |
| September 02, 2026 | 753.25M |
| September 01, 2026 | 742.52M |
| August 31, 2026 | 746.99M |
| August 28, 2026 | 755.49M |
| Date | Value |
|---|---|
| August 27, 2026 | 755.04M |
| August 26, 2026 | 765.32M |
| August 25, 2026 | 770.24M |
| August 24, 2026 | 767.11M |
| August 21, 2026 | 789.01M |
| August 20, 2026 | 767.56M |
| August 19, 2026 | 786.78M |
| August 18, 2026 | 752.36M |
| August 17, 2026 | 732.24M |
| August 14, 2026 | 742.97M |
| August 13, 2026 | 743.87M |
| August 12, 2026 | 746.10M |
| August 11, 2026 | 737.16M |
| August 10, 2026 | 738.95M |
| August 07, 2026 | 728.67M |
| August 06, 2026 | 707.66M |
| August 05, 2026 | 703.19M |
| August 04, 2026 | 721.07M |
| August 03, 2026 | 721.52M |
| July 31, 2026 | 690.68M |
| July 30, 2026 | 700.96M |
| July 29, 2026 | 721.07M |
| July 28, 2026 | 698.27M |
| July 27, 2026 | 658.94M |
| July 24, 2026 | 639.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 196.37B |
| AngioDynamics, Inc. | 587.18M |
| Alphatec Holdings, Inc. | 2.040B |
| AtriCure, Inc. | 2.711B |
| Baxter International, Inc. | 18.82B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.088M |
| Revenue (Quarterly) | 56.01M |
| Total Expenses (Quarterly) | 60.10M |
| EPS Diluted (Quarterly) | -0.0919 |
| Gross Profit Margin (Quarterly) | 79.54% |
| Profit Margin (Quarterly) | -7.30% |
| Earnings Yield | -1.85% |
| Normalized Earnings Yield | -1.848 |